TY - JOUR
T1 - Recovery of the brain after intraventricular hemorrhage
AU - Cheng, Bokun
AU - Ballabh, Praveen
N1 - Funding Information:
I sincerely thank Dr. Jessica Kurian, MD from the Department of Radiology at Albert Einstein College of Medicine for providing the ultrasound images. Authors research work is supported by NIH grants RO1 NS110760 and RO1NS117390-01A1.
Funding Information:
I sincerely thank Dr. Jessica Kurian, MD from the Department of Radiology at Albert Einstein College of Medicine for providing the ultrasound images. Authors research work is supported by NIH grants RO1 NS110760 and RO1NS117390-01A1 .
Publisher Copyright:
© 2021
PY - 2022/2
Y1 - 2022/2
N2 - Intraventricular hemorrhage (IVH) remains a major complication of prematurity, worldwide. The severity of IVH is variable, ranging from a tiny germinal matrix bleed to a moderate-to-large ventricular hemorrhage or periventricular hemorrhagic infarction. Survivors with IVH often suffer from hydrocephalus and white matter injury. There is no tangible treatment to prevent post-hemorrhagic cerebral palsy, cognitive deficits, or hydrocephalus in these infants. White matter injury is attributed to blood-induced damage to axons and maturing oligodendrocyte precursors, resulting in reduced myelination and axonal loss. Hydrocephalus results from obstructed CSF circulation by blood clots, increased CSF production, and reduced CSF absorption by lymphatics and arachnoid villi. Several strategies to promote neurological recovery have shown promise in animal models, including the elimination of blood and blood products, alleviating cerebral inflammation and oxidative stress, as well as promoting survival and maturation of oligodendrocyte precursors. The present review integrates novel mechanisms of brain injury in IVH and the imminent therapies to alleviate post-hemorrhagic white matter injury and hydrocephalus in the survivors with IVH.
AB - Intraventricular hemorrhage (IVH) remains a major complication of prematurity, worldwide. The severity of IVH is variable, ranging from a tiny germinal matrix bleed to a moderate-to-large ventricular hemorrhage or periventricular hemorrhagic infarction. Survivors with IVH often suffer from hydrocephalus and white matter injury. There is no tangible treatment to prevent post-hemorrhagic cerebral palsy, cognitive deficits, or hydrocephalus in these infants. White matter injury is attributed to blood-induced damage to axons and maturing oligodendrocyte precursors, resulting in reduced myelination and axonal loss. Hydrocephalus results from obstructed CSF circulation by blood clots, increased CSF production, and reduced CSF absorption by lymphatics and arachnoid villi. Several strategies to promote neurological recovery have shown promise in animal models, including the elimination of blood and blood products, alleviating cerebral inflammation and oxidative stress, as well as promoting survival and maturation of oligodendrocyte precursors. The present review integrates novel mechanisms of brain injury in IVH and the imminent therapies to alleviate post-hemorrhagic white matter injury and hydrocephalus in the survivors with IVH.
KW - Inflammation
KW - Oligodendrocyte progenitor cells
KW - Oxidative stress
KW - Post-hemorrhagic hydrocephalus
KW - Stem cells
KW - White matter injury
KW - intraventricular hemorrhage
UR - http://www.scopus.com/inward/record.url?scp=85104580826&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85104580826&partnerID=8YFLogxK
U2 - 10.1016/j.siny.2021.101224
DO - 10.1016/j.siny.2021.101224
M3 - Article
C2 - 33888444
AN - SCOPUS:85104580826
SN - 1744-165X
VL - 27
JO - Seminars in Fetal and Neonatal Medicine
JF - Seminars in Fetal and Neonatal Medicine
IS - 1
M1 - 101224
ER -